Literature DB >> 6288366

Cushing's syndrome: problems in management.

D C Aron, J W Findling, P A Fitzgerald, P H Forsham, C B Wilson, J B Tyrrell.   

Abstract

CS comprises a group of disorders characterized by hypercortisolism. The variety of causes--pituitary-dependent CS (CD), adrenal tumor, and the ectopic ACTH syndrome--necessitates a variety of therapies--surgical, radiotherapeutic, and medical. Once a specific diagnosis is made, specific therapy can be instituted. Although some controversy persists regarding treatment, particularly that of CD, for most patients it is straightforward. However, in our experience with more than 60 patients, therapeutic dilemmas can arise in a number of circumstances, e.g. the patient with the radiologically normal sella or recurrent CD after adrenalectomy. In addition, the treatment of such conditions as the large ACTH-producing pituitary tumor, Nelson's syndrome, the malignant ectopic ACTH syndrome, and adrenal carcinoma is not entirely satisfactory. Our approach to these problems is illustrated by seven cases, and we emphasize that the proper management of CS requires both correct diagnosis and the logical application of all available therapies.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6288366     DOI: 10.1210/edrv-3-3-229

Source DB:  PubMed          Journal:  Endocr Rev        ISSN: 0163-769X            Impact factor:   19.871


  8 in total

1.  Evidence for ectopic ACTH production years after bilateral adrenalectomy for Cushing's syndrome: in vivo and in vitro studies.

Authors:  M Boscaro; G Merola; N Sonino; A M Menegus; F Sartori; F Mantero
Journal:  J Endocrinol Invest       Date:  1985-10       Impact factor: 4.256

2.  Recurrent Cushing's disease with low adrenal androgen production.

Authors:  R J Louard; R A Gelfand
Journal:  J Endocrinol Invest       Date:  1991-12       Impact factor: 4.256

3.  Determination of the proliferation and apoptotic index in adrenocorticotropin-secreting pituitary tumors : comparison between micro- and macroadenomas.

Authors:  M Losa; R L Barzaghi; P Mortini; A Franzin; F Mangili; M R Terreni; M Giovanelli
Journal:  Am J Pathol       Date:  2000-01       Impact factor: 4.307

4.  Rebound elevation of cortisol following cyproheptadine withdrawal in Cushing's disease from a pituitary macroadenoma.

Authors:  T C Ooi; Y Twum-Barima
Journal:  J Endocrinol Invest       Date:  1987-04       Impact factor: 4.256

5.  Cushing disease: successful preoperative lateralization of an ACTH-producing pituitary microadenoma by simultaneous bilateral inferior petrosal venous sinus sampling with corticotropin-releasing hormone stimulation.

Authors:  B P Hauffa; H Stolecke; H M Schulte
Journal:  Eur J Pediatr       Date:  1986-12       Impact factor: 3.183

Review 6.  POMC: The Physiological Power of Hormone Processing.

Authors:  Erika Harno; Thanuja Gali Ramamoorthy; Anthony P Coll; Anne White
Journal:  Physiol Rev       Date:  2018-10-01       Impact factor: 37.312

7.  Complete remission of Nelson's syndrome after 1-year treatment with cabergoline.

Authors:  R Pivonello; A Faggiano; F Di Salle; M Filippella; G Lombardi; A Colao
Journal:  J Endocrinol Invest       Date:  1999-12       Impact factor: 4.256

8.  Diagnosis of lung carcinoid with cutaneous hyperpigmentation eight years after bilateral adrenalectomy.

Authors:  M D Rodriguez Vaca; M Angel; I Halperin; J Freixenet; M Marti; M J Martinez Osaba; J Sanchez Lloret; A Palacin; E Vilardell
Journal:  J Endocrinol Invest       Date:  1987-12       Impact factor: 4.256

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.